Trial Outcomes & Findings for A Sleep Intervention in Type 1 Diabetes (NCT NCT03617770)
NCT ID: NCT03617770
Last Updated: 2024-03-06
Results Overview
change in minutes of sleep (actigraphy-derived)
COMPLETED
NA
14 participants
Assessing change between two time points:Week 0 to week 8
2024-03-06
Participant Flow
Participant milestones
| Measure |
Sleep-Opt-In
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
|---|---|---|
|
Overall Study
STARTED
|
9
|
5
|
|
Overall Study
COMPLETED
|
8
|
5
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
| Measure |
Sleep-Opt-In
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
1
|
0
|
Baseline Characteristics
A Sleep Intervention in Type 1 Diabetes
Baseline characteristics by cohort
| Measure |
Sleep-Opt-In
n=9 Participants
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
n=5 Participants
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
Total
n=14 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
30.1 years
STANDARD_DEVIATION 7.1 • n=5 Participants
|
30.0 years
STANDARD_DEVIATION 7.6 • n=7 Participants
|
30.1 years
STANDARD_DEVIATION 7.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
8 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
9 participants
n=5 Participants
|
5 participants
n=7 Participants
|
14 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Assessing change between two time points:Week 0 to week 8change in minutes of sleep (actigraphy-derived)
Outcome measures
| Measure |
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
n=3 Participants
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
|---|---|---|
|
Sleep Duration
|
385 minutes
Standard Deviation 40
|
388 minutes
Standard Deviation 39
|
PRIMARY outcome
Timeframe: Assessing change between two time points: from week 0 to week 8Change in sleep regularity (variability)
Outcome measures
| Measure |
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
n=3 Participants
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
|---|---|---|
|
Sleep Regularity
|
46 minutes
Standard Deviation 20
|
56 minutes
Standard Deviation 8
|
SECONDARY outcome
Timeframe: Change between two time points, week 0 to week 8HbA1c (A1C%)
Outcome measures
| Measure |
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
n=3 Participants
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
|---|---|---|
|
HbA1c
|
6.48 % of glucose saturation on hemoglobin
Standard Deviation 0.74
|
6.7 % of glucose saturation on hemoglobin
Standard Deviation 1.4
|
SECONDARY outcome
Timeframe: Assessing change between two time points: from week 0 to week 8Change in glucose variability (CV%) (continuous glucose monitor derived)
Outcome measures
| Measure |
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
n=3 Participants
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
|---|---|---|
|
Glucose Variability
|
34.4 percentage of CV
Standard Deviation 4.6
|
31.6 percentage of CV
Standard Deviation 5.0
|
SECONDARY outcome
Timeframe: Assessing change between two time points: from week 0 to week 8Change in Diabetes Distress Scale score, 6-point, 17-item Likert scale. The 17 items are summed. The sum score is divided by 17 to provide a mean item score. Higher scores indicate greater distress. Score interpretation: \< 2.0 = little distress 2.0-2.9 = moderate distress 3.0 or greater = hah distress
Outcome measures
| Measure |
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
|
Healthy Living
n=3 Participants
Health education
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
|
|---|---|---|
|
Diabetes Distress
|
1.2 change in score on a scale
Standard Deviation 0.23
|
3.1 change in score on a scale
Standard Deviation 1.36
|
Adverse Events
Sleep-Opt-In
Healthy Living
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Pamela Martyn-Nemeth
University of Illinois at Chicago
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place